BK1310

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BK1310, covering 2025-01-03 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of BK1310 in Healthy Infants [Phase 3]